+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs



High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs



ChemoTherapy 42(1): 37-46



The ability of double and triple combinations of antimicrobials with different mechanisms of action, such as teicoplanin, meropenem, gentamicin and sparfloxacin, to achieve synergisms was investigated in vitro on some moderate-level gentamicin-resistant (MLGR: 8 < or = MIC < or = 256 mg/l) and high-level gentamicin-resistant (HLGR: MIC > 500 mg/l) enterococci. On MLGR strains, a constant synergistic effect was achieved by a combination of teicoplanin with gentamicin or with meropenem, while generally addition, sometimes close to synergism, was exhibited by gentamicin-meropenem, gentamicin-sparfloxacin and teicoplanin-sparfloxacin associations. Triple combinations of teicoplanin, meropenem and gentamicin, or teicoplanin, sparfloxacin and gentamicin, always showed a remarkable advantage in terms of synergism over double combinations. On HLGR enterococci, the only double association showing an additive effect, sometimes close to synergism, was teicoplanin plus meropenem, while the triple combination of teicoplanin with gentamicin and meropenem always showed a marked synergistic effect. An effect very close to synergism was also shown by the combination of teicoplanin with sparfloxacin and gentamicin.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008774384

Download citation: RISBibTeXText

PMID: 8751265

DOI: 10.1159/000239420


Related references

In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci. Journal of Antimicrobial ChemoTherapy 42(6): 836-838, 1998

In vitro antibacterial activity of seven Indian spices against high level gentamicin resistant strains of enterococci. Archives of Medical Science 11(4): 863-868, 2015

Antimicrobial activity of isepamicin sch21420 1 n hapa gentamicin b combinations with cefotaxime ceftazidime ceftriaxone ciprofloxacin imipenem mezlocillin and piperacillin tested against gentamicin resistant and susceptible gram negative bacilli and enterococci. Journal of Chemotherapy 3(5): 289-294, 1991

Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. Journal of Antimicrobial ChemoTherapy 37(4): 727-736, 1996

Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. ChemoTherapy 39(5): 302-309, 1993

Synergistic antimicrobial combinations against enterococci possessing the mid-level gentamicin resistance gene aph -lc. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 37: 136, 1997

In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients. PharmacoTherapy 14(1): 89-94, 1994

In vitro activity of investigational fluoroquinolones, alone and in combination, versus enterococci with and without high-level gentamicin resistance. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 33: 313, 1993

In vitro activity of temafloxacin and eight other antibiotics against gentamicin resistant gmr and gentamicin sensitive gms enterococci. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 31: 132, 1991

In-vitro susceptibility studies of mid-level, gentamicin resistant enterococci. Abstracts of the General Meeting of the American Society for Microbiology 96: 149, 1996

Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates. Chemotherapy 39(4): 248-253, 1993

High-level gentamicin resistant enterococci and quinupristin/dalfopristin resistant E faecium from ground pork purchased from grocery stores. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 41: 140, 2001

The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. Journal of Hospital Infection 50(2): 145-154, 2002